PostPartum Haemorrhage
  PPH affects approximately 2% of all women who give birth: PPH is a significant contributor to severe maternal morbidity and long-term disability as well as a number of other severe maternal conditions generally associated with more substantial blood loss, including shock and organ dysfunction.*  Clinically, 75-80% of postpartum hemorrhages are due to uterine atony.

*WHO recommendations for the prevention and treatment of postpartum haemorrhage. 2012.
Physiological Solution
After delivery, the arteries that fed the placenta during pregnancy are broken. To prevent bleeding, the uterus enlarged during pregnancy naturally contracts to "strangle" these arteries. However, when the uterus is not able to contract naturally (uterine atony), the arteries continue to bleed. HemoGYN does not apply a parietal pressure on the uterus, but on the contrary create a negative pressure within the uterus to stimulate and amplify the natural contractions of the uterus. And it works beautifully.
Evidence
Vacuum Device for Hemostasis in Obstetrics and Gynecology. Feasibility Study for Postpartum Hemorrhage; Ongoing clinical trial;  NCT02816203.

Intra uterine hemostatic device using vacuum in postpartum heamorrhage: French moncentric prospective clinical study; V. Equy et al; presented at GNGOF 2018.
COME MEET WITH US DURING THE 6th EDITION OF
BIRTH : CLINICAL CHALLENGES IN LABOR AND DELIVERY

SEPTEMBER 30, 2020 - OCTOBER 3, 2020 - VALENCIA , SPAIN

CONTACT US

Hemosquid is looking for a RAQA professional - position based in Grenoble, France
Interested in joining the team? Please contact us.
Address
2 avenue de Vignate 38610, Gières, France
Contact